1Q23 results beat and expect gradual recovery
Expect $3.5bn CB dilutive effect to be short-term
Net profit +3.5x YoY in 2022 but below expectations; Attractive yield of 20%
GAC Group (2238 HK) We expect 4Q22 NP to fall on equity income
Core net profit in 2022 +53% YoY in line with expectation; Margin recovery in 4Q
Overseas CXO/ life science upstream 2Q24 review: life science upstream continuing to expect demand recovery
Expect a profit turnaround in 2023E
Natural gas HDT +14.8x YoY in Oct on low base; Expect momentum to continue; Weichai our top pick
what-can-we-expect-in-china-in-2018
China's Economy:Money and Credit Growth Beats Expectations; the Central Bank might Slightly Rein in Its Pace of Monetary Loosening